Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin J Samelson-Jones

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Blood|January 29, 2021
Activated protein C has a regulatory role in factor VIII functionAmelia R Wilhelm, Nicole A Parsons, Benjamin J Samelson-Jones, et al.
Blood Advances|March 3, 2021
Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variantsBenjamin J Samelson-Jones, Jonathan D Finn, Leslie J Raffini, et al.
Blood Advances|March 14, 2025
Loss of factor VIII in zebrafish rebalances antithrombin deficiency but has a limited bleeding diathesisRaghunath Azhwar, Catherine E Richter, Megan S Griffin, et al.
Journal of Thrombosis and Haemostasis : JTH|May 24, 2023
A review of the rationale for gene therapy for hemophilia A with inhibitors: one-shot tolerance and treatment?Leonard A Valentino, Margareth C Ozelo, Roland W Herzog, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 4, 2022
Successful treatment of intracardiac thrombosis in the presence of fulminant myocarditis requiring ECMO associated with COVID-19Erika J Mejia, Matthew J O'Connor, Benjamin J Samelson-Jones, et al.
Thrombosis Research|September 7, 2018
Padua FIXa resistance to Protein S and a potential therapy for hyperactive FIXaWilliam E Plautz, Rima Chattopadhyay, Ester I Goldfeld, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 16, 2022
Appendix to the Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions: Pediatric ConsiderationsHoracio Padua, Anne Marie Cahill, Rush Chewning, et al.
Blood|July 10, 2024
Enhanced procoagulant activity of select hemophilia B causing factor IX variants with emicizumabKyumin Lee, Julia Q Chau, Yani B Suber, et al.
Journal of Thrombosis and Haemostasis : JTH|February 26, 2021
Factor IX assay discrepancies in the setting of liver gene therapy using a hyperfunctional variant factor IX-PaduaMary M Robinson, Lindsey A George, Marcus E Carr, et al.
Molecular Therapy. Methods & Clinical Development|February 20, 2024
AAV gene therapy in companion dogs with severe hemophilia: Real-world long-term data on immunogenicity, efficacy, and quality of lifeBhavya S Doshi, Benjamin J Samelson-Jones, Timothy C Nichols, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Blood|January 29, 2021
Activated protein C has a regulatory role in factor VIII functionAmelia R Wilhelm, Nicole A Parsons, Benjamin J Samelson-Jones, et al.
Blood Advances|March 3, 2021
Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variantsBenjamin J Samelson-Jones, Jonathan D Finn, Leslie J Raffini, et al.
Blood Advances|March 14, 2025
Loss of factor VIII in zebrafish rebalances antithrombin deficiency but has a limited bleeding diathesisRaghunath Azhwar, Catherine E Richter, Megan S Griffin, et al.
Journal of Thrombosis and Haemostasis : JTH|May 24, 2023
A review of the rationale for gene therapy for hemophilia A with inhibitors: one-shot tolerance and treatment?Leonard A Valentino, Margareth C Ozelo, Roland W Herzog, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 4, 2022
Successful treatment of intracardiac thrombosis in the presence of fulminant myocarditis requiring ECMO associated with COVID-19Erika J Mejia, Matthew J O'Connor, Benjamin J Samelson-Jones, et al.
Thrombosis Research|September 7, 2018
Padua FIXa resistance to Protein S and a potential therapy for hyperactive FIXaWilliam E Plautz, Rima Chattopadhyay, Ester I Goldfeld, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 16, 2022
Appendix to the Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions: Pediatric ConsiderationsHoracio Padua, Anne Marie Cahill, Rush Chewning, et al.
Blood|July 10, 2024
Enhanced procoagulant activity of select hemophilia B causing factor IX variants with emicizumabKyumin Lee, Julia Q Chau, Yani B Suber, et al.
Journal of Thrombosis and Haemostasis : JTH|February 26, 2021
Factor IX assay discrepancies in the setting of liver gene therapy using a hyperfunctional variant factor IX-PaduaMary M Robinson, Lindsey A George, Marcus E Carr, et al.
Molecular Therapy. Methods & Clinical Development|February 20, 2024
AAV gene therapy in companion dogs with severe hemophilia: Real-world long-term data on immunogenicity, efficacy, and quality of lifeBhavya S Doshi, Benjamin J Samelson-Jones, Timothy C Nichols, et al.
Pageof 6